About Proteona
Proteona is a Healthcare company based in Singapore (Singapore) founded in 2016 by Jonathan Adam Scolnick, and was acquired by Singleron in March 2022. Single cell proteogenomics-based therapeutics are developed and provided. Proteona offers products and services including MobiuSCOPE, PythoN i™, and Tensor. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Proteomics. Its legal entity is Proteona Pte. Ltd.
Company details
Proteona was established in 2016 in Singapore within the biotechnology sector. Therapeutics grounded in single cell proteogenomics are offered, with operations focused on advanced cellular analysis. The ESCAPE Technology platform is employed for protein expression profiling at the single cell level. This suite of technologies relies on DNA barcoded antibodies to enable detailed proteogenomic insights. Key leadership includes co-founder Jonathan Adam Scolnick and executive director Charles Goldstein.
- Headquarters Singapore, Singapore
- Founders Jonathan Adam Scolnick
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website proteona.com
- Social LinkedIn X
- Acquired by Singleron (Mar 2022)
- Legal Name Proteona Pte. Ltd
Products & Services of Proteona
Proteona offers a comprehensive portfolio of products and services, including MobiuSCOPE, PythoN i™, and Tensor.
Kit for full length single cell RNA sequencing applications
System for processing tissues for single cell analysis
Automated instrument for single cell library preparation
Investors in Proteona
Proteona has secured backing from 1 investor. Prominent investors backing the company include Singleron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis | 2018 | singleron.bio | Hagen, Germany |
Investor details for Proteona
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Proteona
2 people are tracked at Proteona (2 in leadership).
| Name | Role | Group |
|---|---|---|
Jonathan Adam Scolnick | Co-Founder | Leadership |
Charles Goldstein | Executive Director | Leadership |
Complete people profiles for Proteona
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Proteona
2 dated milestones of Proteona across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Proteona is founded.
- Exit Acquired by Singleron.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Proteona
Complete news archive for Proteona
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proteona
Proteona was founded in 2016.
Proteona is headquartered in Singapore, Singapore.
Annual revenue of Proteona is $268.36K as on Dec 31, 2019.
Proteona was established in 2016 in Singapore within the biotechnology sector. Therapeutics grounded in single cell proteogenomics are offered, with operations focused on advanced cellular analysis. The ESCAPE Technology platform is employed for protein expression profiling at the single cell level. This suite of technologies relies on DNA barcoded antibodies to enable detailed proteogenomic insights. Key leadership includes co-founder Jonathan Adam Scolnick and executive director Charles Goldstein.
Proteona offers MobiuSCOPE, PythoN i™, and Tensor.
Proteona has 1 investor. Key investors include Singleron.
Proteona operates through Proteona Pte. Ltd.
Yes. Proteona was acquired by Singleron in March 2022.